Inactive Instrument
Acura Pharmaceuticals, Inc. Stock Other OTC
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.28M 2.87M 2.66M 2.44M 4.61M 316M 4.68M 31.76M 12.45M 155M 12.31M 12.04M 533M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.99M 2.77M 2.54M 4.8M 329M 4.88M 33.07M 12.96M 161M 12.82M 12.54M 555M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 6.66K | |
| +0.21% | -0.79% | +56.02% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| +0.31% | -0.50% | +5.65% | +410.05% | 23.48B | |
| +1.04% | +2.52% | -15.21% | -14.28% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -2.97% | +32.73% | -33.30% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| +0.63% | +0.43% | +27.16% | +183.24% | 14.06B | |
| Average | +1.18% | -2.44% | +42.71% | +181.11% | 25.95B | |
| Weighted average by Cap. | +1.74% | -2.34% | +42.69% | +140.38% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.13M 2.89M 2.66M 5.02M 344M 5.1M 34.59M 13.56M 168M 13.41M 13.11M 580M | 1.56M 1.37M 1.27M 1.16M 2.2M 151M 2.23M 15.14M 5.94M 73.75M 5.87M 5.74M 254M |
| Net income | -1.21M -1.06M -979K -900K -1.7M -116M -1.73M -11.7M -4.59M -57M -4.54M -4.44M -196M | -879K -770K -712K -655K -1.24M -84.76M -1.26M -8.52M -3.34M -41.47M -3.3M -3.23M -143M |
| Net Debt | 5.86M 5.13M 4.74M 4.36M 8.23M 565M 8.37M 56.73M 22.24M 276M 21.99M 21.51M 952M | 135K 118K 109K 101K 190K 13.02M 193K 1.31M 513K 6.37M 507K 496K 21.95M |
Employees
-
